S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.73 CNY -3.99% Market Closed
Market Cap: 35.4B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Relative Value

The Relative Value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 32.9 CNY. Compared to the current market price of 31.73 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Undervalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
32.9 CNY
Undervaluation 4%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
17
Median 3Y
9.5
Median 5Y
9.5
Industry
2.5
Forward
8.5
vs History
53
vs Industry
7
Median 3Y
55.5
Median 5Y
56.1
Industry
21.9
Forward
54
vs History
50
vs Industry
13
Median 3Y
32.7
Median 5Y
29.6
Industry
16.5
vs History
46
vs Industry
3
Median 3Y
132.8
Median 5Y
72.8
Industry
23.6
vs History
44
vs Industry
19
Median 3Y
4
Median 5Y
4.1
Industry
2.1
vs History
61
vs Industry
16
Median 3Y
8.7
Median 5Y
9
Industry
2.6
Forward
8
vs History
63
vs Industry
15
Median 3Y
12.7
Median 5Y
12.8
Industry
5.2
vs History
65
vs Industry
6
Median 3Y
55
Median 5Y
56.7
Industry
13.3
Forward
31.7
vs History
65
vs Industry
7
Median 3Y
55
Median 5Y
56.7
Industry
16.6
Forward
50.8
vs History
47
vs Industry
13
Median 3Y
30.3
Median 5Y
27.2
Industry
15.6
vs History
49
vs Industry
3
Median 3Y
86.7
Median 5Y
60.1
Industry
19.1
vs History
49
vs Industry
19
Median 3Y
4.2
Median 5Y
4.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shenzhen Salubris Pharmaceuticals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
34.6B CNY 8.9 56.7 52.5 52.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top